The US Food and Drug Administration declined to grant accelerated approval to an experimental Alzheimer’s drug, donanemab, and requested additional data from Eli Lilly and Company, the drug maker. More Alzheimer’s disease…
Category: Alzheimer’s disease
FDA decision on experimental Alzheimer’s drug expected this week
The US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental dementia drug lecanemab, according to Eisai and Biogen, the companies that make the drug….
Graphic Medicine: A Personal Story
By Jill L. Newmark ~ When the idea for an exhibition on graphic medicine was initially introduced in the Exhibition Program at the National Library Continue reading Source: NLM
Autism and Alzheimer’s on the Web
By Maureen Harlow Capturing websites and keeping copies of them for the future to represent how they looked and what they said at a certain Continue reading Source: NLM
Alzheimer’s Disease Collection Received
By Margaret Kaiser Recently, the Library received from the National Institute on Aging’s Alzheimer’s Disease Education and Referral (ADEAR) Center, an excellent collection of public Continue reading Source: NLM